Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globe Life (GL) Cash & Equivalents (2016 - 2019)

Globe Life's Cash & Equivalents history spans 11 years, with the latest figure at $67.3 million for Q1 2019.

  • For Q1 2019, Cash & Equivalents fell 24.01% year-over-year to $67.3 million; the TTM value through Mar 2019 reached $67.3 million, down 24.01%, while the annual FY2018 figure was $121.0 million, 2.08% up from the prior year.
  • Cash & Equivalents reached $67.3 million in Q1 2019 per GL's latest filing, down from $121.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $121.0 million in Q4 2018 to a low of $61.4 million in Q4 2015.
  • Average Cash & Equivalents over 5 years is $88.8 million, with a median of $82.4 million recorded in 2016.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 55.67% in 2017, then dropped 24.01% in 2019.
  • A 5-year view of Cash & Equivalents shows it stood at $61.4 million in 2015, then rose by 24.08% to $76.2 million in 2016, then surged by 55.67% to $118.6 million in 2017, then increased by 2.08% to $121.0 million in 2018, then tumbled by 44.36% to $67.3 million in 2019.
  • Per Business Quant, the three most recent readings for GL's Cash & Equivalents are $67.3 million (Q1 2019), $121.0 million (Q4 2018), and $88.6 million (Q1 2018).